por
Cinza-Estévez, Zurina,
Resik-Aguirre, Sonia,
Figueroa-Baile, Nelvis L.,
Oquendo-Martínez, Rachel,
Campa-Legrá, Ivan,
Tejeda-Fuentes, Alina,
Rivero-Caballero, Marila,
González-García, Gloria,
Chávez-Chong, Cristina O.,
Alonso-Valdés, Marel,
Hernández-Bernal, Francisco,
Lemos-Pérez, Gilda,
Campal-Espinosa, Ana,
Freyre-Corrales, Giselle,
Benítez-Gordillo, Delia,
Gato-Orozco, Evelyn,
Pérez Bartutis, Greter Susana,
Mesa-Pedroso, Iliana,
Bueno-Alemani, Nilda,
Infante-Aguilar, Elizabeth,
Rodríguez Reinoso, José Luis,
Melo-Suarez, Grettel,
Limonta-Fernández, Miladys,
Ayala-Ávila, Marta,
Muzio-González, Verena L.
Publicado 2023
“…METHODS: A double-blinded, multicentre, randomised, phase 1/2 clinical trial was conducted in nine polyclinics in the province of
Camagüey, Cuba. Healthy children and adolescents were stratified according to age (3–11 years old, or 12–18 years old) and they were randomly assigned (1:1; block size four) in two dosage level groups of vaccine to receive three intramuscular doses of 25 μg or 50 μg of RBD, 14 days apart. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto